Assurance in vaccine efficacy clinical trial design based on immunological responses
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Assurance in vaccine efficacy clinical trial design based on immunological responses ; day:12 ; month:07 ; year:2021 ; extent:10
Biometrical journal ; (12.07.2021) (gesamt 10)
- Creator
-
Callegaro, Andrea
Zahaf, Toufik
Tibaldi, Fabian
- DOI
-
10.1002/bimj.202100015
- URN
-
urn:nbn:de:101:1-2021071315020606111579
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Callegaro, Andrea
- Zahaf, Toufik
- Tibaldi, Fabian
Other Objects (12)
An immunological autobiography: my year as a COVID-19 vaccine trial participant
Publisher Correction: An immunological autobiography: my year as a COVID-19 vaccine trial participant
Standardized study performance, quality assurance, and quality control in a cluster-randomized trial: the Pneumococcal Vaccine Schedules trial
Dissecting molecular and immunological mechanisms of influenza vaccine responsiveness
Immunological and polyfunctional T cell profiling following therapy with DPX-Survivac as a predictive tool of vaccine efficacy
In-depth immunological analysis of prototypic adjuvants for vaccine formulations
HRCT Surrogate for Vaccine Efficacy?
Systematic review of dengue vaccine efficacy
Towards a vaccine against the European lyssaviruses : a structural and immunological approach
Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine
Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
An immunological autobiography: my year as a COVID-19 vaccine trial participant
Publisher Correction: An immunological autobiography: my year as a COVID-19 vaccine trial participant
Standardized study performance, quality assurance, and quality control in a cluster-randomized trial: the Pneumococcal Vaccine Schedules trial
Dissecting molecular and immunological mechanisms of influenza vaccine responsiveness
Immunological and polyfunctional T cell profiling following therapy with DPX-Survivac as a predictive tool of vaccine efficacy
In-depth immunological analysis of prototypic adjuvants for vaccine formulations
HRCT Surrogate for Vaccine Efficacy?
Systematic review of dengue vaccine efficacy
Towards a vaccine against the European lyssaviruses : a structural and immunological approach
Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine
Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
An immunological autobiography: my year as a COVID-19 vaccine trial participant
Publisher Correction: An immunological autobiography: my year as a COVID-19 vaccine trial participant
Standardized study performance, quality assurance, and quality control in a cluster-randomized trial: the Pneumococcal Vaccine Schedules trial
Dissecting molecular and immunological mechanisms of influenza vaccine responsiveness
Immunological and polyfunctional T cell profiling following therapy with DPX-Survivac as a predictive tool of vaccine efficacy
In-depth immunological analysis of prototypic adjuvants for vaccine formulations
HRCT Surrogate for Vaccine Efficacy?
Systematic review of dengue vaccine efficacy
Towards a vaccine against the European lyssaviruses : a structural and immunological approach
Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine
Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis